Guardant Health (GH) Tops Q1 EPS by 28c

Guardant Health (NASDAQ: GH) reported Q1 EPS of ($1.06), $0.28 better than the analyst estimate of ($1.34). Revenue for the quarter came in at $128.7 million versus the consensus estimate of $117.88 million.

GUIDANCE:

Guardant Health sees FY2023 revenue of $535-545 million, versus the consensus of $533 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Creatd files Form S-1 and reports Q1 2026 financial results
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance